Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
SELLAS Life Sciences Group, Inc. has filed 1,267 SEC EDGAR filings since 07 Feb 2007

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
PRE 14A File 001-33958

PRE 14A

Filing date
30 May 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
02 May 2017
Reporting date
22 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33958

DEFA14A

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33958

DEF 14A

Filing date
20 Apr 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
03 Apr 2017
Reporting date
01 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
28 Mar 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
23 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
15 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
13 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-84090

SC 13G/A filing

Filing date
09 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
21 Feb 2017
Reporting date
21 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84090

SC 13G

Filing date
17 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84090

SC 13G

Filing date
17 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84090

SABBY 13G GALE 2.15.17

Filing date
15 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

GALENA BIOPHARMA, INC.

Filing date
10 Feb 2017
Reporting date
08 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .